ER
AVNS

Enlightenment Research’s Avanos Medical AVNS Stock Holding History

Enlightenment Research’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-200
Closed -$9K – 149
2018
Q4 		$9K Buy
+200
New +$10.5K 0.01% 584

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Enlightenment Research's AVNS Position: Q1 2019 in Review

Enlightenment Research sold out of Avanos Medical (AVNS) in Q1 2019, closing a stake of 200 shares — an estimated $9K sold.

Enlightenment Research first reported a position in AVNS in Q4 2018 and held it in 1 quarter. The position peaked at $9K in Q4 2018. 338 funds tracked by Wall St. Rank hold AVNS as of Q1 2019.

  • Enlightenment Research reported no remaining Avanos Medical position as of Q1 2019 after selling out during the quarter.
  • Enlightenment Research sold 200 Avanos Medical shares in Q1 2019, an estimated $9K.
  • Enlightenment Research first reported a position in Avanos Medical in Q4 2018 and held it in 1 quarter.
  • Enlightenment Research's Avanos Medical position peaked at $9K in Q4 2018.
  • 338 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2019.

Based on Enlightenment Research's 13F filing for Q1 2019, filed 3 May 2019.